EyePoint, Inc. Repayments of Lines of Credit
EyePoint, Inc. (EYPT) reported Repayments of Lines of Credit of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLinesOfCredit · last filed 2025-03-06
- EyePoint, Inc. repayments of lines of credit for the quarter ending 2024-12-31 was $0.00.
- EyePoint, Inc. repayments of lines of credit for the quarter ending 2024-09-30 was $0.00.
- EyePoint, Inc. repayments of lines of credit for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. repayments of lines of credit for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. repayments of lines of credit for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- EyePoint, Inc. repayments of lines of credit for fiscal 2023 was $15.78M, a 52.77% decline from fiscal 2022.
- EyePoint, Inc. repayments of lines of credit for fiscal 2022 was $33.40M.
- EyePoint, Inc. repayments of lines of credit for fiscal 2021 was $0.00.
| Period end | Repayments of Lines of Credit 3 month | Repayments of Lines of Credit 6 month | Repayments of Lines of Credit 9 month | Repayments of Lines of Credit 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $0.00 derived: sum of 3 quarters · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2025-03-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-03-06 | $0.00 derived: sum of 4 quarters · filed 2025-03-06 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $0.00 derived: sum of 3 quarters · filed 2025-03-06 | $5.29M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $5.29M derived: sum of 3 quarters · filed 2025-03-06 | $15.78M 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $5.29M derived: sum of 2 quarters · filed 2024-11-07 | $15.78M 10-Q · filed 2024-11-07 | $27.24M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $5.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $15.78M 10-Q · filed 2024-08-08 | $27.24M derived: sum of 3 quarters · filed 2024-08-08 | $37.72M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $10.48M 10-Q · filed 2024-05-09 | $21.95M derived: sum of 2 quarters · filed 2024-05-09 | $32.42M derived: sum of 3 quarters · filed 2024-05-09 | $42.90M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $11.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $21.94M derived: sum of 2 quarters · filed 2024-03-08 | $32.42M derived: sum of 3 quarters · filed 2024-03-08 | $33.40M 10-K · filed 2024-03-08 |
| 2022-09-30 | $10.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $20.95M derived: sum of 2 quarters · filed 2023-11-03 | $21.93M 10-Q · filed 2023-11-03 | $21.93M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $10.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $11.46M 10-Q · filed 2023-08-04 | $11.46M derived: sum of 3 quarters · filed 2023-08-04 | |
| 2022-03-31 | $984.00K 10-Q · filed 2023-05-04 | $984.00K derived: sum of 2 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $0.00 10-K · filed 2023-03-10 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-04 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |